Abstract
In their January 2010 Drug Safety Update, the UK MHRA warns that treatment with either bevacizumab [Avastin] or sunitinib [Sutent
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.2165/00128415-201113350-00007
Journal: Reactions Weekly | Publication Date: Jan 1, 2011 |
In their January 2010 Drug Safety Update, the UK MHRA warns that treatment with either bevacizumab [Avastin] or sunitinib [Sutent
Join us for a 30 min session where you can share your feedback and ask us any queries you have